Therapies on the Horizon in EGFR Exon 20–Positive Lung Cancer

Jan 15, 03:15 PM

Nagashree Seetharamu, MD and with Luis E. Raez, MD discuss the evolving treatment landscape of EGFR exon 20–mutated lung cancer.